Reviewing IRB Responsibilities in Multi-Site Research

Multi-site research studies present unique challenges for Institutional Review Boards (IRBs) and research teams. With the NIH single IRB (sIRB) mandate reshaping the landscape of collaborative research, understanding the distribution and coordination of IRB responsibilities across multiple sites has never been more critical.

Whether you're a clinical trial sponsor, principal investigator, or research coordinator managing a multi-site study, this comprehensive guide will help you navigate the complex responsibilities involved in multi-site IRB oversight.

The Evolution of Multi-Site IRB Review

Historically, multi-site studies required each participating institution to conduct its own IRB review, leading to duplicative efforts, inconsistent decisions, and significant delays. The NIH single IRB mandate, which took effect in January 2018, fundamentally changed this approach by requiring a single IRB of record for multi-site studies funded by the NIH.

This shift has streamlined the review process but also created new questions about responsibility, accountability, and coordination. Understanding these responsibilities is essential for study success and participant protection.

Single IRB vs. Local IRB: Understanding the Framework

Before diving into specific responsibilities, it's important to understand the two primary models for multi-site IRB review:

Single IRB (sIRB) Model

Under the single IRB model, one IRB serves as the reviewing IRB of record for all sites participating in the study. This centralized approach:

  • Provides a single ethical and regulatory review
  • Ensures consistency across all sites
  • Reduces redundancy and accelerates study start-up
  • Requires clear delineation of responsibilities between the sIRB and participating sites

The central IRB approach has become the standard for most federally-funded multi-site research and is increasingly adopted by commercial sponsors as well.

Multiple Local IRB Model

In some cases, particularly for non-NIH funded research or studies with significant local context variations, multiple local IRBs may still review the same protocol. This approach:

  • Allows for local institutional oversight
  • May result in varying requirements across sites
  • Requires careful coordination to manage different timelines and decisions

Primary IRB of Record: Core Responsibilities

The IRB of record bears primary responsibility for the ethical review and ongoing oversight of the research across all participating sites. Key responsibilities include:

Initial Protocol Review

The reviewing IRB must:

  • Evaluate the scientific merit and study design
  • Assess risks and benefits to participants
  • Review recruitment materials and procedures
  • Examine informed consent documents for clarity and completeness
  • Ensure adequate protections for vulnerable populations
  • Verify investigator qualifications and conflicts of interest

For guidance on proper documentation requirements, consult our IRB submission requirements checklist.

Continuing Review and Monitoring

The IRB of record maintains ongoing oversight through:

  • Periodic continuing review: Evaluating study progress, adverse events, and any new information that may affect risk-benefit assessment
  • Amendment review: Assessing protocol modifications, consent form changes, and other study updates
  • Safety monitoring: Reviewing adverse events and unanticipated problems across all sites
  • Compliance monitoring: Ensuring adherence to the approved protocol and regulatory requirements

Site-Specific Considerations

While providing centralized review, the IRB of record must also:

  • Review site-specific information such as local recruitment plans
  • Consider site-specific context that may affect participant safety or rights
  • Assess local investigator qualifications and facilities
  • Evaluate site-specific consent procedures or modifications

Participating Site Responsibilities

Even under an sIRB model, participating sites retain important responsibilities that cannot be delegated to the central IRB:

Local Context Assessment

Sites must:

  • Evaluate whether the centrally-approved protocol is appropriate for their local population
  • Assess whether additional local protections are needed
  • Ensure compliance with applicable state and local laws
  • Verify that local resources and facilities are adequate

Institutional Authorization

Each participating institution must:

  • Formally authorize the research to be conducted at their site
  • Execute reliance agreements or authorization agreements with the sIRB
  • Ensure local investigators are qualified and appropriately trained
  • Confirm adequate resources exist to conduct the research safely

Investigator Oversight

Local institutions remain responsible for:

  • Ensuring investigators complete required training
  • Managing conflicts of interest
  • Monitoring investigator performance and compliance
  • Addressing local investigator concerns or complaints

Local Regulatory Compliance

Sites must ensure compliance with:

  • State and local laws that may be more restrictive than federal regulations
  • Institutional policies and procedures
  • Additional reporting requirements to institutional officials
  • HIPAA and other privacy regulations specific to their jurisdiction

Study Sponsor Responsibilities in Multi-Site Research

Sponsors coordinating multi-site studies have critical responsibilities that facilitate effective IRB oversight:

Selecting the Appropriate IRB

Sponsors must:

  • Choose an IRB with appropriate expertise for the research type
  • Verify the IRB is registered and has appropriate accreditation
  • Ensure the IRB has capacity to review multi-site studies efficiently
  • Consider whether a commercial IRB or academic IRB is most appropriate

Coordinating Site Authorization

Sponsors typically:

  • Facilitate reliance agreements between the sIRB and participating sites
  • Provide standardized templates and documentation
  • Track authorization status across all sites
  • Ensure all sites have executed necessary agreements before study initiation

Information Management and Communication

Sponsors must establish systems for:

  • Collecting and submitting site-specific information to the sIRB
  • Distributing sIRB decisions and communications to all sites
  • Reporting adverse events and protocol deviations from all sites to the sIRB
  • Maintaining centralized documentation of IRB correspondence

Amendment Coordination

When protocol changes are necessary, sponsors must:

  • Submit amendments to the sIRB for review
  • Communicate approved changes to all participating sites
  • Ensure sites implement changes according to the approved timeline
  • Track implementation across all sites

Principal Investigator Responsibilities

Principal investigators (PIs) at each participating site maintain distinct responsibilities:

Protocol Adherence

PIs must:

  • Conduct research according to the IRB-approved protocol
  • Ensure study staff understand and follow approved procedures
  • Implement protocol amendments as approved by the IRB
  • Maintain accurate and complete research records

Safety Reporting

PIs are responsible for:

  • Promptly reporting adverse events according to the protocol and IRB requirements
  • Identifying and reporting unanticipated problems involving risks to participants
  • Reporting protocol deviations and violations
  • Implementing safety measures when necessary

Informed Consent Process

PIs must ensure:

  • Only IRB-approved consent forms are used
  • The consent process is properly documented
  • Participants receive all required information
  • Consent is obtained before any research procedures begin

For more guidance on creating effective consent documents, see our article on how to write participant-friendly informed consent forms.

Ongoing Communication

PIs should:

  • Maintain communication with the sponsor and sIRB
  • Report changes in investigator status or site personnel
  • Notify relevant parties of issues affecting participant safety or study conduct
  • Participate in continuing review processes

Reliance Agreements: Formalizing the Relationship

Reliance agreements (also called authorization agreements) are essential documents that formalize the relationship between the sIRB and participating sites. These agreements should clearly specify:

Scope of Review

  • Which aspects of the research the sIRB will review
  • Which aspects remain under local institutional oversight
  • Any exceptions or limitations to the reliance relationship

Responsibilities and Obligations

  • What the sIRB commits to provide (review, communications, documentation)
  • What the relying institution commits to maintain (local compliance, investigator oversight)
  • How amendments, adverse events, and other changes will be handled

Communication Protocols

  • How the sIRB will communicate with participating sites
  • Who receives sIRB correspondence at each site
  • How sites will submit site-specific information

Terms and Termination

  • Duration of the reliance relationship
  • Conditions under which either party may terminate
  • Procedures for transitioning oversight if the relationship ends

Common Challenges and How to Address Them

Challenge 1: Communication Breakdowns

Multi-site studies involve numerous stakeholders, creating potential for miscommunication.

Solutions: - Establish clear communication protocols from the outset - Designate specific contact persons at each level (sponsor, sIRB, sites) - Use centralized platforms for document sharing and updates - Schedule regular coordination calls for complex studies

Challenge 2: Varying Local Requirements

Different states and institutions may have requirements that differ from federal regulations.

Solutions: - Conduct thorough local context assessments before site activation - Build flexibility into protocols where appropriate - Engage local IRB or compliance offices early to identify potential conflicts - Document how local requirements are being met

Challenge 3: Delayed Site Activation

Negotiating reliance agreements and obtaining local authorization can delay study start-up.

Solutions: - Use standardized reliance agreement templates - Begin the authorization process in parallel with protocol development - Provide sites with clear instructions and all necessary documentation upfront - Track authorization status and follow up proactively

Challenge 4: Inconsistent Reporting

Sites may interpret adverse event reporting requirements differently, leading to inconsistent reporting.

Solutions: - Provide clear, written guidance on reporting requirements and timelines - Conduct investigator meetings to review reporting procedures - Establish a central point of contact for reporting questions - Implement standardized reporting forms and systems

Best Practices for Effective Multi-Site IRB Oversight

1. Plan Early and Thoroughly

Develop your multi-site oversight strategy during study timeline planning. Consider:

  • Which IRB model best suits your study
  • How you'll manage reliance agreements
  • What resources you'll need for coordination
  • Potential regulatory or institutional barriers

2. Create Clear Documentation

Maintain comprehensive documentation including:

  • A master responsibility matrix showing who is responsible for what
  • Standard operating procedures for multi-site coordination
  • Templates for common communications and submissions
  • A centralized tracking system for all sites

3. Invest in Training

Ensure all stakeholders understand their responsibilities:

  • Train site staff on the sIRB model and their ongoing obligations
  • Educate local institutional officials about reliance relationships
  • Provide investigators with clear guidance on reporting requirements
  • Update training as responsibilities or procedures change

4. Leverage Technology

Use technology to streamline coordination:

  • Electronic IRB submission systems that support multi-site studies
  • Centralized document repositories accessible to all authorized parties
  • Automated notification systems for important updates
  • Tracking databases for site authorization and activation status

5. Maintain Flexibility

Recognize that one size doesn't always fit all:

  • Be prepared to accommodate reasonable site-specific variations
  • Build contingency plans for sites that cannot rely on the sIRB
  • Allow sufficient time for unexpected institutional requirements
  • Stay open to adjusting processes based on experience

Regulatory Compliance Across Multiple Sites

Maintaining regulatory compliance in multi-site research requires attention to multiple regulatory frameworks:

Federal Regulations

All sites must comply with:

  • The Common Rule (45 CFR 46)
  • FDA regulations if applicable (21 CFR 50, 56)
  • HIPAA Privacy Rule
  • Good Clinical Practice (GCP) guidelines

State and Local Laws

Sites must identify and comply with:

  • State laws governing research conduct
  • Local institutional policies
  • Professional licensing requirements
  • Additional privacy or consent requirements

International Considerations

For international multi-site studies, additional considerations include:

  • Country-specific regulations and guidelines
  • Cultural appropriateness of research procedures
  • Translation and cultural adaptation of consent documents
  • Local ethics committee requirements

Moving Forward with Confidence

Successful multi-site research requires clear understanding and coordination of IRB responsibilities across all parties involved. By establishing well-defined roles, maintaining open communication, and implementing robust systems for oversight and coordination, research teams can navigate the complexities of multi-site IRB review while protecting participants and maintaining scientific integrity.

The single IRB model has streamlined multi-site research, but success still depends on careful planning, clear documentation, and ongoing collaboration among sponsors, IRBs, institutions, and investigators. Each party must understand not only their own responsibilities but also how their role fits into the larger oversight framework.

Partner with Elemental IRB for Multi-Site Research Excellence

Navigating multi-site IRB responsibilities doesn't have to be overwhelming. Elemental IRB specializes in serving as the IRB of record for multi-site clinical trials, offering streamlined review processes, experienced oversight, and dedicated support for sponsors and research teams.

Our team understands the unique challenges of coordinating research across multiple sites and provides:

  • Efficient single IRB review for multi-site studies
  • Expert guidance on reliance agreements and site authorization
  • Clear communication and responsive support throughout the study lifecycle
  • Transparent processes that facilitate compliance and coordination

Ready to simplify your multi-site research oversight? Contact Elemental IRB today to learn how we can support your next multi-site study with expert, efficient, and ethical IRB review.